array(1) { [0]=> object(WP_Term)#10619 (11) { ["term_id"]=> int(234) ["name"]=> string(12) "Legal Reader" ["slug"]=> string(12) "legal-reader" ["term_group"]=> int(0) ["term_taxonomy_id"]=> int(234) ["taxonomy"]=> string(17) "whitepaper-source" ["description"]=> string(0) "" ["parent"]=> int(0) ["count"]=> int(3) ["filter"]=> string(3) "raw" ["term_order"]=> string(1) "0" } }

Hunter Shkolnik Discusses Teva’s $23 Billion Offer

November 7, 2019

Source: Legal Reader

Teva Pharmaceutical Industries Ltd.’s proposed $23 billion drug giveaway over it’s suggesting to settle the opioid lawsuits against it will likely cost the company a fraction of that figure, according to industry experts. When Teva announced the value of the donated medicine – a generic version of opioid addiction treatment Suboxone – it based the figure on the drug’s list price, which does not account for significant discounts it will receive.

Featured Attorneys

Partner and Attorney Hunter J. Shkolnik

More Publications

Legal Reader

Our Locations

Please Contact Us for an In-Person Appointment